Background Multiple metrics evaluate the efficacy of psoriasis treatment, but interestingly,
the correlation between the mostly widely used clinical trial efficacy end point, the physician …

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin
and joint manifestations affecting approximately 2% of the population. In the first 5 parts of …

Objective To compare the prevalence and incidence of type 2 diabetes mellitus between
patients with psoriasis and those without psoriasis. Data Sources MEDLINE, EMBASE, and …

Previous epidemiological studies have demonstrated a high prevalence of cardiovascular
(CV) risk factors in psoriasis patients, including metabolic syndrome, cigarette smoking …

Psoriasis is an inflammatory skin disease associated with increased cardiovascular
comorbidity. Smoking is associated with an increased risk of cardiovascular disease, and …

Importance The total cost of psoriasis in the United States is unknown. Defining the US
economic burden of psoriasis is needed because it provides the foundation for research …

Background Psoriasis is a chronic inflammatory disease associated with an increased
cardiovascular risk. Metabolic syndrome is a significant predictor of cardiovascular events …

Background Severe psoriasis is associated with excess mortality and increased risk of
cardiovascular death. Population‐based data evaluating cause‐specific mortality in patients …

Hypertension as a multifactorial pathology is one of the most important cardiovascular risk
factors, affecting up to 30‐40% of the general population. Complex immune responses are …

BACKGROUND: Psoriasis is a predictor of morbidity. It is important to determine the extent to
which psoriasis remains undiagnosed. OBJECTIVE: To determine the prevalence of …